Cargando…

Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?

Detalles Bibliográficos
Autor principal:	Han, Ki Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Lipidology and Atherosclerosis 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379111/ https://www.ncbi.nlm.nih.gov/pubmed/32821710 http://dx.doi.org/10.12997/jla.2019.8.2.204

Ejemplares similares

Intensity of Statin Treatment in Korean Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol
por: Sim, Doo Sun, et al.
Publicado: (2019)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol
por: Lee, Soo Youn, et al.
Publicado: (2016)

Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"
por: Fazio, Sergio, et al.
Publicado: (2001)

Should We Tip Our CAPs to Statins?
por: Simpson, A. John, et al.
Publicado: (2019)

Low‐density lipoprotein cholesterol and stroke: How low should we go?
por: Lui, David TW, et al.
Publicado: (2020)

Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis
por: Sun, Haixia, et al.
Publicado: (2015)

Cholesterol lowering for secondary prevention: What statin dose should we use?
por: Josan, Kiranbir, et al.
Publicado: (2007)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Cholesterol in Relation to COVID-19: Should We Care about It?
por: Radenkovic, Dina, et al.
Publicado: (2020)

Lower Intensified Target LDL-c Level of Statin Therapy Results in a Higher Risk of Incident Diabetes: A Meta-Analysis
por: Cai, Rongrong, et al.
Publicado: (2014)

Forecasting Cholesterol Management-End of the Statin Gold Rush?
por: Crownover, Brian K., et al.
Publicado: (2006)

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
por: Sakuma, Masashi, et al.
Publicado: (2022)

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
por: Kim, Kyungpil, et al.
Publicado: (2014)

Should we start vasopressors very early in septic shock?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy
por: Watson, Karol E.
Publicado: (2008)

“Back to the future”: after the pandemic we must intensify recovery()
por: Ramírez-Rodríguez, José M., et al.
Publicado: (2021)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Safety and Efficacy of Extremely Low LDL-Cholesterol Levels and Its Prospects in Hyperlipidemia Management
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2018)

Is interleukin-6 the link between low LDL cholesterol and increased non-cardiovascular mortality in the elderly?
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Low LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2009)

Modelling approach to simulate reductions in LDL cholesterol levels after combined intake of statins and phytosterols/-stanols in humans
por: Eussen, Simone RBM, et al.
Publicado: (2011)

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
por: Postmus, Iris, et al.
Publicado: (2014)

Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol
por: Hong, Jinyoung, et al.
Publicado: (2023)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
por: Feldt, Maria, et al.
Publicado: (2020)

Questioning the importance of LDL cholesterol: don’t throw the baby out with the bathwater!
por: Raal, FJ
Publicado: (2008)

Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users
por: Sung, Ki-Chul, et al.
Publicado: (2019)

High LDL cholesterol and statin use were independently associated with lower eight-year mortality in a cohort free from terminal illness, cardiovascular disease, and diabetes at baseline
por: Thulesius, Hans
Publicado: (2014)

Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines
por: Ross, Elsie Gyang, et al.
Publicado: (2016)

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
por: Murakami, Naoya, et al.
Publicado: (2022)

Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
por: Kang, You-Ri, et al.
Publicado: (2022)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

Are Patients with Low Non-HDL Cholesterol “Non-responders” to Statin Therapy on Coronary Plaque Regression?
por: Koba, Shinji
Publicado: (2016)

The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
por: Atamanalp, S. Selcuk, et al.
Publicado: (2013)

Atherosclerosis, Inflammation, and Genetics - And you Thought it Was Just LDL-cholesterol
por: Gowdak, Luis Henrique Wolff
Publicado: (2020)

Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease
por: Masuda, Daisaku, et al.
Publicado: (2022)

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
por: Laufs, Ulrich, et al.
Publicado: (2016)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d66ch4u5g6u460q8i08vjc4ig8